Molecular Oncology & Cancer Genetics

Molecular Oncology and Cancer Genetics is a rapidly evolving field that focuses on understanding the genetic basis of cancer and how this information can be used to develop personalised therapies. By analysing the genetic makeup of a patient's tumour, we can identify specific mutations that are driving cancer and target those mutations with precision medicine.

Our team of experts includes oncologists, geneticists, pathologists, and research scientists, who work together to provide comprehensive care to our patients. We use state-of-the-art technologies such as next-generation sequencing, liquid biopsies, and bioinformatics to analyse tumour samples and identify genetic abnormalities that may be contributing to the development and progression of cancer.

Max Healthcare's Molecular Oncology and Cancer Genetics Speciality offers a range of services to diagnose and treat cancer. Some of the services provided by this speciality include:

• Genetic counselling: Genetic counsellors help patients understand their risk of developing cancer based on their family history and genetic makeup. They can also provide guidance on genetic testing and assist in making informed decisions about their healthcare.

• Cancer screening: The speciality provides comprehensive cancer screening programs that use advanced imaging technologies and genetic testing to detect cancer at an early stage.

• Molecular testing: The molecular oncology team uses advanced molecular diagnostic tests to identify specific genetic mutations in cancer cells. This information helps oncologists develop personalised treatment plans for patients.

• Targeted therapy: The speciality provides targeted therapy for cancer patients, which involves using drugs that target specific genetic mutations in cancer cells. This approach can be more effective and less toxic than traditional chemotherapy.

• Immunotherapy: The molecular oncology team also provides immunotherapy, which is a type of cancer treatment that uses the body's own immune system to fight against cancer.

• Clinical trials: The speciality offers patients access to cutting-edge clinical trials that test new cancer treatments and therapies.

• Support services: In addition to medical services, the speciality provides a range of support services to help patients cope with the emotional and psychological aspects of cancer. These services include counselling, support groups, and educational resources.

We have the latest technology, which includes

• Next-Generation Sequencing (NGS): This advanced method allows researchers to read and understand large portions of a person's genetic code quickly and at a lower cost. It helps identify genetic changes that drive cancer development.

• Single-Cell Sequencing: By examining individual cells within a tumour, scientists can uncover valuable information about tumour diversity and understand how different cells contribute to its growth. This helps in developing more personalised treatment strategies.

• Liquid Biopsies: Instead of traditional tissue biopsies, liquid biopsies involve analysing tiny amounts of tumour DNA or cancer cells that circulate in the bloodstream or other bodily fluids. This non-invasive approach helps monitor treatment response and detect genetic changes over time.

• CRISPR-Cas9 Gene Editing: With this groundbreaking technology, scientists can make precise changes to specific genes, helping them understand how these genes influence cancer development. It has the potential to unlock new treatment targets and therapies.

• Multi-Omics Approaches: Integrating data from different "omics" fields, such as genomics, transcriptomics, proteomics, and metabolomics, provides a more comprehensive view of the complex molecular processes in cancer. It helps researchers identify patterns and potential therapeutic targets.

• Artificial Intelligence (AI) and Machine Learning: These technologies are used to analyse large amounts of data and find patterns that may not be readily apparent to humans. AI and machine learning algorithms assist in predicting treatment responses, identifying high-risk patients, and improving clinical decision-making.

At Max Healthcare, we are committed to providing compassionate care to our patients, and we understand that a cancer diagnosis can be a difficult and overwhelming experience. That's why we offer a multidisciplinary approach to cancer care, with a team of experts who are dedicated to providing personalised care and support to our patients and their families.

If you or a loved one is diagnosed with cancer, we invite you to learn more about our Molecular Oncology and Cancer Genetics speciality and the services we offer.

Review

Reviewed by Dr. Devavrat Arya, Director, Cancer Care / Oncology, Medical Oncology on 18-May-2023.